Each agent differs in molecular structure, half-life, and dosing frequency, but all share the core mechanism of GLP-1 receptor activation that influences multiple organ systems, including indirect effects on hepatic function
That is a workforce that is paying close attention to how they are treated
Discussion Within the last six weeks the FDA approved oral semaglutide for obesity and Truveta Data allowed for early characterization of initial prescribing and dispensing patterns
It works by slowing stomach emptying, boosting insulin sensitivity, and signaling fullness to the brain
Key Takeaways GLP-1 medications can reduce appetite and food intake, which may make it harder to meet daily nutrient needs during weight loss
contact your clinical team